Cargando…
Medical Characteristics and Therapeutic Approaches Used to Treat Primary and Secondary Infertile Women
BACKGROUND: Inability to conceive is a major problem during reproductive age. This study aimed to describe medical characteristics and different approaches to get better the management of infertility among women referring to some public and private health centers in Morocco. METHODS: Overall, 619 in...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379602/ https://www.ncbi.nlm.nih.gov/pubmed/30788297 |
_version_ | 1783396123709276160 |
---|---|
author | BENKSIM, Abdelhafid AIT ADDI, Rachid ELKHOUDRI, Noureddine CHERKAOUI, Mohamed |
author_facet | BENKSIM, Abdelhafid AIT ADDI, Rachid ELKHOUDRI, Noureddine CHERKAOUI, Mohamed |
author_sort | BENKSIM, Abdelhafid |
collection | PubMed |
description | BACKGROUND: Inability to conceive is a major problem during reproductive age. This study aimed to describe medical characteristics and different approaches to get better the management of infertility among women referring to some public and private health centers in Morocco. METHODS: Overall, 619 infertile women referring to public and private health centers in Marrakech-Safi region were selected by simple random sampling method, between 1 Oct 2013 and 31 Dec 2015. The socio-economic data, demographic characteristics, medical and obstetric variables and types of infertility treatments were simultaneously collected by questionnaire and health record data. The univariate logistic regression analyses were used to determine different infertility treatments. Statistical significance was set at 0.05. RESULTS: The rate of primary and secondary infertility was 67.37%, and 32.63%, respectively. In comparison to secondary infertility, primary infertile women with high socio-economic level and low average age have used many fertility drugs and assisted reproductive technologies (Clomifene citrate (45.01 vs. 29.20%), injectable gonadotropins (09.35 vs. 3.96%), dydrogesterone (35.08 vs. 23.26%), intrauterine insemination (3.83 vs. 0.49%), and in-vitro fertilisation (3.11 vs. 1.48%)). CONCLUSION: The use of infertility’s treatment is limited in Morocco. Outside of medical coverage, the infertility management requires permanent efforts, financial supports, psychological assistance and serious dialogue between all the stakeholders. |
format | Online Article Text |
id | pubmed-6379602 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Tehran University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-63796022019-02-20 Medical Characteristics and Therapeutic Approaches Used to Treat Primary and Secondary Infertile Women BENKSIM, Abdelhafid AIT ADDI, Rachid ELKHOUDRI, Noureddine CHERKAOUI, Mohamed Iran J Public Health Original Article BACKGROUND: Inability to conceive is a major problem during reproductive age. This study aimed to describe medical characteristics and different approaches to get better the management of infertility among women referring to some public and private health centers in Morocco. METHODS: Overall, 619 infertile women referring to public and private health centers in Marrakech-Safi region were selected by simple random sampling method, between 1 Oct 2013 and 31 Dec 2015. The socio-economic data, demographic characteristics, medical and obstetric variables and types of infertility treatments were simultaneously collected by questionnaire and health record data. The univariate logistic regression analyses were used to determine different infertility treatments. Statistical significance was set at 0.05. RESULTS: The rate of primary and secondary infertility was 67.37%, and 32.63%, respectively. In comparison to secondary infertility, primary infertile women with high socio-economic level and low average age have used many fertility drugs and assisted reproductive technologies (Clomifene citrate (45.01 vs. 29.20%), injectable gonadotropins (09.35 vs. 3.96%), dydrogesterone (35.08 vs. 23.26%), intrauterine insemination (3.83 vs. 0.49%), and in-vitro fertilisation (3.11 vs. 1.48%)). CONCLUSION: The use of infertility’s treatment is limited in Morocco. Outside of medical coverage, the infertility management requires permanent efforts, financial supports, psychological assistance and serious dialogue between all the stakeholders. Tehran University of Medical Sciences 2018-12 /pmc/articles/PMC6379602/ /pubmed/30788297 Text en Copyright© Iranian Public Health Association & Tehran University of Medical Sciences http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article BENKSIM, Abdelhafid AIT ADDI, Rachid ELKHOUDRI, Noureddine CHERKAOUI, Mohamed Medical Characteristics and Therapeutic Approaches Used to Treat Primary and Secondary Infertile Women |
title | Medical Characteristics and Therapeutic Approaches Used to Treat Primary and Secondary Infertile Women |
title_full | Medical Characteristics and Therapeutic Approaches Used to Treat Primary and Secondary Infertile Women |
title_fullStr | Medical Characteristics and Therapeutic Approaches Used to Treat Primary and Secondary Infertile Women |
title_full_unstemmed | Medical Characteristics and Therapeutic Approaches Used to Treat Primary and Secondary Infertile Women |
title_short | Medical Characteristics and Therapeutic Approaches Used to Treat Primary and Secondary Infertile Women |
title_sort | medical characteristics and therapeutic approaches used to treat primary and secondary infertile women |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379602/ https://www.ncbi.nlm.nih.gov/pubmed/30788297 |
work_keys_str_mv | AT benksimabdelhafid medicalcharacteristicsandtherapeuticapproachesusedtotreatprimaryandsecondaryinfertilewomen AT aitaddirachid medicalcharacteristicsandtherapeuticapproachesusedtotreatprimaryandsecondaryinfertilewomen AT elkhoudrinoureddine medicalcharacteristicsandtherapeuticapproachesusedtotreatprimaryandsecondaryinfertilewomen AT cherkaouimohamed medicalcharacteristicsandtherapeuticapproachesusedtotreatprimaryandsecondaryinfertilewomen |